Evidence map›Paper›PMID 21686186›Full record

ReviewInternational journal of molecular sciences2011

Nanomedicine: application areas and development prospects.

Houria Boulaiz, Pablo J Alvarez, Alberto Ramirez, Juan A Marchal, Jose Prados, Fernando Rodríguez-Serrano, Macarena Perán, Consolación Melguizo, Antonia Aranega

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Houria BoulaizDepartment of Human Anatomy and Embryology, Institute of Biopathology and Regenerative Medicine (IBIMER), School of Medicine, University of Granada, Granada 18071, Spain; E-Mails: pablo.alvarez.exts@juntadeandalucia.es (P.J.A.); alrari80@gmail.com (A.R.); jmarchal@ugr.es (J.A.M.); jcpradois@ugr.es (J.P.); fernrs@ugr.es (F.R.-S.); melguizo@ugr.es (C.M.).
Pablo J Alvarez
Alberto Ramirez
Juan A Marchal
Jose Prados
Fernando Rodríguez-Serrano
Macarena Perán
Consolación Melguizo
Antonia Aranega

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanotechnology, along with related concepts such as nanomaterials, nanostructures and nanoparticles, has become a priority area for scientific research and technological development. Nanotechnology, i.e., the creation and utilization of materials and devices at nanometer scale, already has multiple applications in electronics and other fields. However, the greatest expectations are for its application in biotechnology and health, with the direct impact these could have on the quality of health in future societies. The emerging discipline of nanomedicine brings nanotechnology and medicine together in order to develop novel therapies and improve existing treatments. In nanomedicine, atoms and molecules are manipulated to produce nanostructures of the same size as biomolecules for interaction with human cells. This procedure offers a range of new solutions for diagnoses and "smart" treatments by stimulating the body's own repair mechanisms. It will enhance the early diagnosis and treatment of diseases such as cancer, diabetes, Alzheimer's, Parkinson's and cardiovascular diseases. Preventive medicine may then become a reality.

Indexed as

Biosensing TechniquesDendrimersDrug Delivery SystemsGoldLab-On-A-Chip DevicesLiposomesMetal NanoparticlesMicellesNanomedicineNanostructuresQuantum DotsRegenerative MedicineDendrimersGoldLiposomesMicellesdrug deliveryearly diagnosisnanomedicinenanostructures

Identifiers

PMID21686186
PMCPMC3116192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.